|
VPS13A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62680979798324E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.15449904980869E-11 |
| Normal-vs-Stage2 |
5.28410000200097E-08 |
| Normal-vs-Stage3 |
3.67372798848464E-13 |
| Normal-vs-Stage4 |
4.06819022913396E-12 |
| Stage1-vs-Stage2 |
3.255000E-01 |
| Stage1-vs-Stage3 |
1.298200E-02 |
| Stage1-vs-Stage4 |
9.409400E-04 |
| Stage2-vs-Stage3 |
4.220800E-01 |
| Stage2-vs-Stage4 |
1.140180E-01 |
| Stage3-vs-Stage4 |
3.404000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82076576038526E-14 |
| Normal-vs-AfricanAmerican |
4.15809999998462E-06 |
| Normal-vs-Asian |
1.06240000019575E-07 |
| Caucasian-vs-AfricanAmerican |
8.066200E-01 |
| Caucasian-vs-Asian |
8.825600E-01 |
| AfricanAmerican-vs-Asian |
7.449200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91846538655227E-13 |
| Normal-vs-Female |
1.81943349275571E-12 |
| Male-vs-Female |
1.761650E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90710003344918E-09 |
| Normal-vs-Age(41-60Yrs) |
7.48956452412131E-13 |
| Normal-vs-Age(61-80Yrs) |
1.3394951814405E-11 |
| Normal-vs-Age(81-100Yrs) |
3.410200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.955800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.664500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.616200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.978600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.736000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.780300E-03 |
| Classical-VS-Follicular |
6.106400E-01 |
| Classical-VS-Other |
5.347000E-01 |
| Classical-VS-Normal |
1.12389999529228E-08 |
| Tall-VS-Follicular |
3.199700E-02 |
| Tall-VS-Other |
4.506200E-01 |
| Tall-VS-Normal |
3.62270213827287E-11 |
| Follicular-VS-Other |
6.921000E-01 |
| Follicular-VS-Normal |
1.10600000269301E-08 |
| Other-VS-Normal |
3.636300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.12097047994575E-13 |
| Normal-vs-N1 |
8.9985000006898E-08 |
| N0-vs-N1 |
9.094000E-01 |
|
|
